Cargando…
Proteolysis-Targeting Chimeras (PROTACs) in Cancer Therapy: Present and Future
The PROteolysis TArgeting Chimeras (PROTACs) is an innovative technique for the selective degradation of target proteins via the ubiquitin–proteasome system. Compared with traditional protein inhibitor drugs, PROTACs exhibit advantages in the efficacy and selectivity of and in overcoming drug resist...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785308/ https://www.ncbi.nlm.nih.gov/pubmed/36557960 http://dx.doi.org/10.3390/molecules27248828 |